TipRanks
Go Ultimate55% OFF

Jean M. Franchi Insider Profile

4 Followers

Jean M. Franchi, CFO at Disc Medicine, holds 64.33K shares in Disc Medicine (Ticker: IRON), holds ― shares in Merrimack Pharmaceuticals (Ticker: MACK), holds ― shares in Dimension Therapeutics Inc (Ticker: DMTX).

Jean M. Franchi's Trading History

IRON
Disc Medicine
Apr 15, 2026CFOUninformative Sell460.77K$5.20M
BDSX
Biodesix
Apr 02, 2025DirectorUninformative Buy15.98K$2.51M
REPL
Replimune Group
May 18, 2023CFOInformative Sell204.89K$2.27M
DMTX
Dimension Therapeutics Inc
――――
MACK
Merrimack Pharmaceuticals
――――

You May Also Like

Jean M. Franchi insider profile FAQ

What is the percentage of profitable transactions made by Jean M. Franchi?
The percentage of profitable transactions made by Jean M. Franchi is 25%.
What is the average return per transaction made by Jean M. Franchi?
The average return per transaction made by Jean M. Franchi is -2.80%.
What stocks does Jean M. Franchi hold?
Jean M. Franchi holds: IRON, MACK, DMTX, REPL, BDSX stocks.
What was Jean M. Franchi’s latest transaction?
Jean M. Franchi’s latest transaction was an Uninformative Sell of $460.77K.
What was Jean M. Franchi's most profitable transaction?
Jean M. Franchi’s most profitable transaction was an Informative Sell of REPL stock on May 18, 2023. The return on the trade was 67.20%.
What is Jean M. Franchi's role in Disc Medicine?
Jean M. Franchi's role in Disc Medicine is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.